Related Experiment Video
Updated: Oct 2, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
The Roles of microRNAs in Cancer Multidrug Resistance
Lucia Pavlíková1, Mário Šereš1, Albert Breier1,2
1Institute of Molecular Physiology and Genetics, Centre of Bioscience, Slovak Academy of Sciences, Dúbravská Cesta 9, 84005 Bratislava, Slovakia.
Abstract:
Cancer chemotherapy may induce a multidrug resistance (MDR) phenotype. The development of MDR is based on various molecular causes, of which the following are very common: induction of ABC transporter expression; induction/activation of drug-metabolizing enzymes; alteration of the expression/function of apoptosis-related proteins; changes in cell cycle checkpoints; elevated DNA repair mechanisms. Although these mechanisms of MDR are well described, information on their molecular interaction in overall multidrug resistance is still lacking. MicroRNA (miRNA) expression and subsequent RNA interference are candidates that could be important players in the interplay of MDR mechanisms. The regulation of post-transcriptional processes in the proteosynthetic pathway is considered to be a major function of miRNAs. Due to their complementarity, they are able to bind to target mRNAs, which prevents the mRNAs from interacting effectively with the ribosome, and subsequent degradation of the mRNAs can occur. The aim of this paper is to provide an overview of the possible role of miRNAs in the molecular mechanisms that lead to MDR. The possibility of considering miRNAs as either specific effectors or interesting targets for cancer therapy is also analyzed.
Insights
MicroRNAs (miRNAs) may play a key role in how cancer cells develop multidrug resistance (MDR). Understanding miRNA interactions could lead to new cancer therapies targeting MDR mechanisms.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Cancer chemotherapy can lead to multidrug resistance (MDR).
- MDR involves complex molecular mechanisms like ABC transporters, drug-metabolizing enzymes, apoptosis, cell cycle, and DNA repair.
- The interplay between these MDR mechanisms is not fully understood.
Purpose of the Study:
- To explore the potential role of microRNAs (miRNAs) in the molecular mechanisms underlying MDR.
- To analyze miRNAs as potential effectors or therapeutic targets in overcoming MDR.
Main Methods:
- Literature review and analysis of existing research on miRNA function and MDR.
- Investigating the post-transcriptional regulatory role of miRNAs via mRNA binding and degradation.
- Examining the connection between miRNA expression and MDR-associated molecular pathways.
Main Results:
- MicroRNAs regulate post-transcriptional processes, impacting protein synthesis.
- miRNAs can bind to target messenger RNAs (mRNAs), inhibiting translation or promoting degradation.
- This regulatory function positions miRNAs as critical players in the complex network of MDR mechanisms.
Conclusions:
- MicroRNAs are implicated in the development and interplay of MDR mechanisms in cancer.
- miRNAs represent promising candidates for novel therapeutic strategies against MDR.
- Further research into miRNA-mediated regulation is crucial for advancing cancer treatment.
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Treatment Resistant Cancers
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...

